Tag: Emblem Cannabis Corporation

November 7, 2018

Emblem Corp. Announces New Board Appointments

Emblem (TSXV:EMC,OTCQX:EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi to its Board...
September 24, 2018

Emblem Partners With DriveABLE To Support Research That Evaluates Impairment Risk

Emblem (TSXV:EMC,OTCQX:EMMBF) (“Emblem” or the “Company”) today announced it has completed an equity investment in DriveABLE Assessment Centres Inc. (“DriveABLE”),...
September 18, 2018

Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials

Canntab Therapeutics (CSE:PILL) ("Canntab" or the "Company"), today announced the achievement of a milestone with regards to the development of...
September 18, 2018

Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets

Emblem (TSXV:EMC,OTCQX:EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under...
September 13, 2018

Emblem launches Atmosphere, its first oral dose-metered spray

Emblem (TSXV:EMC,OTCQX:EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under...
September 12, 2018

Emblem Signs Supply Agreement with Aphria to Purchase up to 175,000 kg Equivalents of Cannabis Products Over Five Years

Emblem (TSXV:EMC,OTCQX:EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under...
September 6, 2018

UPDATE: Emblem Signs Five-Year Supply Agreement with Compass Cannabis Clinic for Starbuds Canada

Emblem (TSXV:EMC, OTC:EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis...